Easy Access and Express Report Delivery Service
Pet Medicine Market, Global Outlook and Forecast 2024-2030
Report ID
49226
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
118
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Pet Medicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Pet Medicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Pet Medicine, challenges faced by the industry, and potential opportunities for market players. The global Pet Medicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Pet Medicine market presents opportunities for various stakeholders, including Dogs, Cats. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Pet Medicine market. Additionally, the growing consumer demand present avenues for market expansion. The global Pet Medicine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 33%. Key Features: The research report on the Pet Medicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Pet Medicine market. Market Overview: The report provides a comprehensive overview of the Pet Medicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., External Use, Internal Use), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Pet Medicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Pet Medicine market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Pet Medicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Pet Medicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Pet Medicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Pet Medicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Pet Medicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Pet Medicine market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Pet Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Market segment by Type External Use Internal Use Market segment by Application Dogs Cats Other Global Pet Medicine Market Segment Percentages, By Region and Country, 2023 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Boehringer Ingelheim Zoetis Merck Elanco Bayer Virbac Ceva Sante Animale Vetoquinol Bimeda Animal Health Dechra Pharmaceuticals Outline of Major Chapters: Chapter 1: Introduces the definition of Pet Medicine, market overview. Chapter 2: Global Pet Medicine market size in revenue and volume. Chapter 3: Detailed analysis of Pet Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Pet Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Pet Medicine capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Pet Medicine Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Pet Medicine Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Pet Medicine Overall Market Size 2.1 Global Pet Medicine Market Size: 2023 VS 2030 2.2 Global Pet Medicine Revenue, Prospects & Forecasts: 2019-2030 2.3 Global Pet Medicine Sales: 2019-2030 3 Company Landscape 3.1 Top Pet Medicine Players in Global Market 3.2 Top Global Pet Medicine Companies Ranked by Revenue 3.3 Global Pet Medicine Revenue by Companies 3.4 Global Pet Medicine Sales by Companies 3.5 Global Pet Medicine Price by Manufacturer (2019-2024) 3.6 Top 3 and Top 5 Pet Medicine Companies in Global Market, by Revenue in 2023 3.7 Global Manufacturers Pet Medicine Product Type 3.8 Tier 1, Tier 2 and Tier 3 Pet Medicine Players in Global Market 3.8.1 List of Global Tier 1 Pet Medicine Companies 3.8.2 List of Global Tier 2 and Tier 3 Pet Medicine Companies 4 Sights by Product 4.1 Overview 4.1.1 By Type - Global Pet Medicine Market Size Markets, 2023 & 2030 4.1.2 External Use 4.1.3 Internal Use 4.2 By Type - Global Pet Medicine Revenue & Forecasts 4.2.1 By Type - Global Pet Medicine Revenue, 2019-2024 4.2.2 By Type - Global Pet Medicine Revenue, 2025-2030 4.2.3 By Type - Global Pet Medicine Revenue Market Share, 2019-2030 4.3 By Type - Global Pet Medicine Sales & Forecasts 4.3.1 By Type - Global Pet Medicine Sales, 2019-2024 4.3.2 By Type - Global Pet Medicine Sales, 2025-2030 4.3.3 By Type - Global Pet Medicine Sales Market Share, 2019-2030 4.4 By Type - Global Pet Medicine Price (Manufacturers Selling Prices), 2019-2030 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Pet Medicine Market Size, 2023 & 2030 5.1.2 Dogs 5.1.3 Cats 5.1.4 Other 5.2 By Application - Global Pet Medicine Revenue & Forecasts 5.2.1 By Application - Global Pet Medicine Revenue, 2019-2024 5.2.2 By Application - Global Pet Medicine Revenue, 2025-2030 5.2.3 By Application - Global Pet Medicine Revenue Market Share, 2019-2030 5.3 By Application - Global Pet Medicine Sales & Forecasts 5.3.1 By Application - Global Pet Medicine Sales, 2019-2024 5.3.2 By Application - Global Pet Medicine Sales, 2025-2030 5.3.3 By Application - Global Pet Medicine Sales Market Share, 2019-2030 5.4 By Application - Global Pet Medicine Price (Manufacturers Selling Prices), 2019-2030 6 Sights by Region 6.1 By Region - Global Pet Medicine Market Size, 2023 & 2030 6.2 By Region - Global Pet Medicine Revenue & Forecasts 6.2.1 By Region - Global Pet Medicine Revenue, 2019-2024 6.2.2 By Region - Global Pet Medicine Revenue, 2025-2030 6.2.3 By Region - Global Pet Medicine Revenue Market Share, 2019-2030 6.3 By Region - Global Pet Medicine Sales & Forecasts 6.3.1 By Region - Global Pet Medicine Sales, 2019-2024 6.3.2 By Region - Global Pet Medicine Sales, 2025-2030 6.3.3 By Region - Global Pet Medicine Sales Market Share, 2019-2030 6.4 North America 6.4.1 By Country - North America Pet Medicine Revenue, 2019-2030 6.4.2 By Country - North America Pet Medicine Sales, 2019-2030 6.4.3 US Pet Medicine Market Size, 2019-2030 6.4.4 Canada Pet Medicine Market Size, 2019-2030 6.4.5 Mexico Pet Medicine Market Size, 2019-2030 6.5 Europe 6.5.1 By Country - Europe Pet Medicine Revenue, 2019-2030 6.5.2 By Country - Europe Pet Medicine Sales, 2019-2030 6.5.3 Germany Pet Medicine Market Size, 2019-2030 6.5.4 France Pet Medicine Market Size, 2019-2030 6.5.5 U.K. Pet Medicine Market Size, 2019-2030 6.5.6 Italy Pet Medicine Market Size, 2019-2030 6.5.7 Russia Pet Medicine Market Size, 2019-2030 6.5.8 Nordic Countries Pet Medicine Market Size, 2019-2030 6.5.9 Benelux Pet Medicine Market Size, 2019-2030 6.6 Asia 6.6.1 By Region - Asia Pet Medicine Revenue, 2019-2030 6.6.2 By Region - Asia Pet Medicine Sales, 2019-2030 6.6.3 China Pet Medicine Market Size, 2019-2030 6.6.4 Japan Pet Medicine Market Size, 2019-2030 6.6.5 South Korea Pet Medicine Market Size, 2019-2030 6.6.6 Southeast Asia Pet Medicine Market Size, 2019-2030 6.6.7 India Pet Medicine Market Size, 2019-2030 6.7 South America 6.7.1 By Country - South America Pet Medicine Revenue, 2019-2030 6.7.2 By Country - South America Pet Medicine Sales, 2019-2030 6.7.3 Brazil Pet Medicine Market Size, 2019-2030 6.7.4 Argentina Pet Medicine Market Size, 2019-2030 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Pet Medicine Revenue, 2019-2030 6.8.2 By Country - Middle East & Africa Pet Medicine Sales, 2019-2030 6.8.3 Turkey Pet Medicine Market Size, 2019-2030 6.8.4 Israel Pet Medicine Market Size, 2019-2030 6.8.5 Saudi Arabia Pet Medicine Market Size, 2019-2030 6.8.6 UAE Pet Medicine Market Size, 2019-2030 7 Manufacturers & Brands Profiles 7.1 Boehringer Ingelheim 7.1.1 Boehringer Ingelheim Company Summary 7.1.2 Boehringer Ingelheim Business Overview 7.1.3 Boehringer Ingelheim Pet Medicine Major Product Offerings 7.1.4 Boehringer Ingelheim Pet Medicine Sales and Revenue in Global (2019-2024) 7.1.5 Boehringer Ingelheim Key News & Latest Developments 7.2 Zoetis 7.2.1 Zoetis Company Summary 7.2.2 Zoetis Business Overview 7.2.3 Zoetis Pet Medicine Major Product Offerings 7.2.4 Zoetis Pet Medicine Sales and Revenue in Global (2019-2024) 7.2.5 Zoetis Key News & Latest Developments 7.3 Merck 7.3.1 Merck Company Summary 7.3.2 Merck Business Overview 7.3.3 Merck Pet Medicine Major Product Offerings 7.3.4 Merck Pet Medicine Sales and Revenue in Global (2019-2024) 7.3.5 Merck Key News & Latest Developments 7.4 Elanco 7.4.1 Elanco Company Summary 7.4.2 Elanco Business Overview 7.4.3 Elanco Pet Medicine Major Product Offerings 7.4.4 Elanco Pet Medicine Sales and Revenue in Global (2019-2024) 7.4.5 Elanco Key News & Latest Developments 7.5 Bayer 7.5.1 Bayer Company Summary 7.5.2 Bayer Business Overview 7.5.3 Bayer Pet Medicine Major Product Offerings 7.5.4 Bayer Pet Medicine Sales and Revenue in Global (2019-2024) 7.5.5 Bayer Key News & Latest Developments 7.6 Virbac 7.6.1 Virbac Company Summary 7.6.2 Virbac Business Overview 7.6.3 Virbac Pet Medicine Major Product Offerings 7.6.4 Virbac Pet Medicine Sales and Revenue in Global (2019-2024) 7.6.5 Virbac Key News & Latest Developments 7.7 Ceva Sante Animale 7.7.1 Ceva Sante Animale Company Summary 7.7.2 Ceva Sante Animale Business Overview 7.7.3 Ceva Sante Animale Pet Medicine Major Product Offerings 7.7.4 Ceva Sante Animale Pet Medicine Sales and Revenue in Global (2019-2024) 7.7.5 Ceva Sante Animale Key News & Latest Developments 7.8 Vetoquinol 7.8.1 Vetoquinol Company Summary 7.8.2 Vetoquinol Business Overview 7.8.3 Vetoquinol Pet Medicine Major Product Offerings 7.8.4 Vetoquinol Pet Medicine Sales and Revenue in Global (2019-2024) 7.8.5 Vetoquinol Key News & Latest Developments 7.9 Bimeda Animal Health 7.9.1 Bimeda Animal Health Company Summary 7.9.2 Bimeda Animal Health Business Overview 7.9.3 Bimeda Animal Health Pet Medicine Major Product Offerings 7.9.4 Bimeda Animal Health Pet Medicine Sales and Revenue in Global (2019-2024) 7.9.5 Bimeda Animal Health Key News & Latest Developments 7.10 Dechra Pharmaceuticals 7.10.1 Dechra Pharmaceuticals Company Summary 7.10.2 Dechra Pharmaceuticals Business Overview 7.10.3 Dechra Pharmaceuticals Pet Medicine Major Product Offerings 7.10.4 Dechra Pharmaceuticals Pet Medicine Sales and Revenue in Global (2019-2024) 7.10.5 Dechra Pharmaceuticals Key News & Latest Developments 8 Global Pet Medicine Production Capacity, Analysis 8.1 Global Pet Medicine Production Capacity, 2019-2030 8.2 Pet Medicine Production Capacity of Key Manufacturers in Global Market 8.3 Global Pet Medicine Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Pet Medicine Supply Chain Analysis 10.1 Pet Medicine Industry Value Chain 10.2 Pet Medicine Upstream Market 10.3 Pet Medicine Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Pet Medicine Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
